ATR and cancer: Targeting the ATR-CHK1 pathway also impairs S and G2 checkpoints, as well as homologous recombination repair (HRR), causing an accumulation of excess DNA damage and cell death by replication or mitotic catastrophe, especially in cancer cells with intrinsically high RS or impaired DNA repair [22, 23].